$0.917
+0.022 (+2.35%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MRKR Prediction & Forecast by Similar Chart Analysis
Alphio's MRKR stock price prediction model matches the current Marker Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.91 (-0.17%). The 1-week path is $0.89 (-2.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Marker Therapeutics Inc Stock?
Marker Therapeutics Inc is currently not a good buy due to its declining revenue and negative earnings, despite a recent uptick in stock price. The current price is $0.92, and the stock has a low RSI of 37.105, indicating it is oversold. The company reported a significant year-to-date change of -40.49% and a 5-day change of -6.48%, reflecting ongoing struggles. The main risk is its forward P/E ratio of 0, suggesting no expected profitability in the near term, which could deter long-term investors.
MRKR stock price ended at $0.92 on Friday, after rising +2.35%
Marker Therapeutics Inc (MRKR) last closed at $0.9165, gaining +2.35%. These facts feed the 1-day and 1-week MRKR price prediction above.
Forecast Drivers
Marker Therapeutics Inc (MRKR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MRKR, ranked by similarity.
Seasonality analysis for MRKR
Historically the probability of a positive November return for MRKR is 0.00%. January offers the highest probability of a positive month at 32.79%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MRKR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.32 | $0.35 | $0.41 | -62.18% |
| Dec 2026 | $0.28 | $0.29 | $0.37 | -67.93% |
In 2026, Marker Therapeutics Inc (MRKR) is projected to range from $0.28 to $0.41.
Marker Therapeutics Inc 2026 monthly forecast
In Nov 2026, Marker Therapeutics Inc is projected to average $0.35, with a low of $0.32 and high of $0.41.
In Dec 2026, Marker Therapeutics Inc is projected to average $0.29, with a low of $0.28 and high of $0.37.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.